Carnick & Kubik’s Sanofi SNY Stock Holding History

Carnick & Kubik’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$469K	Buy	11,681 +930	+9%	+$37.4K	0.14%	195
2015 Q4	$459K	Buy	10,751 +1,196	+13%	+$55K	0.29%	101
2015 Q3	$454K	Buy	9,555 +375	+4%	+$19.1K	0.32%	110
2015 Q2	$455K	Buy	9,180 +50	+0.5%	+$2.53K	0.37%	104
2015 Q1	$451K	Buy	9,130 +125	+1%	+$5.98K	0.38%	104
2014 Q4	$411K	Buy	9,005 +725	+9%	+$35.2K	0.35%	103
2014 Q3	$467K	Sell	8,280 -650	-7%	-$34.9K	0.43%	95
2014 Q2	$475K	Buy	8,930 +350	+4%	+$18.6K	0.47%	85
2014 Q1	$449K	Sell	8,580 -410	-5%	-$20.8K	0.43%	95
2013 Q4	$482K	Buy	8,990 +375	+4%	+$19.4K	0.44%	82
2013 Q3	$436K	Sell	8,615 -270	-3%	-$13.7K	0.67%	66
2013 Q2	$458K	Buy	+8,885	New	+$473K	0.57%	64

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carnick & Kubik's SNY Position: Q1 2016 in Review

Carnick & Kubik increased its Sanofi (SNY) stake by 8.7% in Q1 2016, buying an estimated $37.4K and bringing the position to 11,681 shares worth $469K. The position accounts for 0.14% of the portfolio, ranked #195.

Carnick & Kubik first reported a position in SNY in Q2 2013 and has held it in 12 quarters since. The position peaked at $482K in Q4 2013. 448 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

Carnick & Kubik held 11,681 shares of Sanofi worth $469K as of Q1 2016.
Carnick & Kubik bought 930 Sanofi shares in Q1 2016, an estimated $37.4K.
Sanofi made up 0.14% of Carnick & Kubik's portfolio in Q1 2016, its #195 holding.
Carnick & Kubik first reported a position in Sanofi in Q2 2013 and has held it in 12 quarters since.
Carnick & Kubik's Sanofi position peaked at $482K in Q4 2013.
448 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.